Literature DB >> 30280401

Bedside Ultrasound Versus Chest Radiography for Detection of Pulmonary Edema: A Prospective Cohort Study.

William M Wooten1, Lynn E T Shaffer2, Lisa A Hamilton1.   

Abstract

OBJECTIVES: Chest radiography has been the preferred imaging study to assess pulmonary congestion. However, chest radiography interpretation is influenced by the level of expertise and high interobserver variability. Lung ultrasound (US) may produce more objective findings through evaluation of vertical comet tail artifacts known as B-lines, which are created by a decrease in the ratio of alveolar air to fluid pulmonary content. Few studies have directly compared chest radiography to bedside US against a reference standard for the diagnosis of pulmonary edema. This study compared the sensitivity and specificity of bedside US and chest radiography in diagnosing pulmonary edema.
METHODS: This prospective observational cohort study involved adult patients presenting to the emergency department of an urban tertiary hospital with dyspnea. The primary outcome was the presence or absence of pulmonary edema, as indicated by B-lines on a bedside lung US examination or radiologist-interpreted chest radiography. Patients underwent a US examination within about 1 hour of chest radiography. The final diagnosis from the discharge summary served as the reference standard.
RESULTS: Ninety-nine patients were enrolled; 32.3% had congestive heart failure, and 40.4% had chronic obstructive pulmonary disease. Bedside US showed significantly higher sensitivity (96%) compared to chest radiography (65%; P < .001). Of 18 patients with negative radiographic findings and a discharge diagnosis of pulmonary edema, 16 (89%) had positive US findings (P < .001).
CONCLUSIONS: Bedside US has the potential to identify pulmonary edema more accurately than chest radiography. As current practice within the United States uses chest radiography, reflecting American College of Cardiology Foundation/American Heart Association guidelines for management of heart failure, the results of this study warrant further evaluation.
© 2018 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  dyspnea; heart failure; lung ultrasound; point-of-care testing; pulmonary edema; sensitivity and specificity

Mesh:

Year:  2018        PMID: 30280401     DOI: 10.1002/jum.14781

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  6 in total

1.  Combined use of cardiopulmonary ultrasound in the diagnosis of pulmonary edema in patients with heart failure: a retrospective analysis.

Authors:  Mengjun Shen; Hongwei Chen; Yang Cong
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

2.  Modern diagnostics in emergency medicine.

Authors:  Jan Niederdöckl; Nina Buchtele; Michael Schwameis; Hans Domanovits
Journal:  Wien Klin Wochenschr       Date:  2021-03       Impact factor: 1.704

3.  Dynamic assessment of lung injury by ultrasound in patients with acute paraquat poisoning.

Authors:  Peng Shen; Qianqian Wang; Wenlong Yu; Yichen Gu; Xianbin Song; Yunchao Shi
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

4.  Point-of-care ultrasound of the heart and lungs in patients with respiratory failure: a pragmatic randomized controlled multicenter trial.

Authors:  M Riishede; A T Lassen; G Baatrup; P I Pietersen; N Jacobsen; K N Jeschke; C B Laursen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-04-26       Impact factor: 2.953

Review 5.  Research on Detection of Sterol Doping in Sports by Electrochemical Sensors: A Review.

Authors:  Yunyan Sun
Journal:  J Anal Methods Chem       Date:  2022-09-08       Impact factor: 2.594

6.  Feasibility and efficacy of lung ultrasound to investigate pulmonary complications in patients who developed postoperative Hypoxaemia-a prospective study.

Authors:  Chen Xie; Kai Sun; Yueyang You; Yue Ming; Xiaoling Yu; Lina Yu; Jiapeng Huang; Min Yan
Journal:  BMC Anesthesiol       Date:  2020-09-01       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.